Sree Chitra Tirunal Institute Develops Innovative Technology for COVID-19 Test


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ medicircle-sree-chitra-tirunal-institute-develops-innovative-technology-for-covid19-test
Sree Chitra Tirunal Institute develops magnetic nanoparticle-based RNA extraction kit for PCR and LAMP tests for COVID-19

Chitra Magna, an innovative RNA extraction kit, has been developed by Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an Institution of National Importance under the Department of Science and Technology, Govt. of India, as an innovative technology for isolating RNA from swabs for COVID 19 tests.

SARS-COV-2, the causative virus of COVID-19 pandemic, is an RNA virus-- a long single-stranded polymeric substance present in all living cells that carries the genetic information of the organism necessary for life. One of the critical steps in detecting this virus is by confirming the presence of the RNA of the virus in the sample taken from the throat or nose. The sample collected is transported under specified conditions in a viral transport medium to the testing laboratory.

The protocol for the kit uses magnetic nanoparticles to capture and concentrate the RNA from the patient sample. This is of significant advantage because even if some viral RNA disintegrates during storage and transportation of the patient samples, all of it is captured by the magnetic bead-based extraction technology. The magnetic nanoparticle beads bind to the viral RNA and, when exposed to a magnetic field, give a highly purified and concentrated level of RNA. As the yield of PCR or LAMP test is dependent on getting an adequate quantity of viral RNA, this innovation enhances the chances of identifying positive cases. The Institute has filed for a patent for this technology, which is simpler than in imported kits.

Chitra Magna can be used to extract high purity RNA from patient samples not only for LAMP testing but also for the RT-PCR test. The first step of isolating high quality and high concentration of RNA without degradation is critical to the outcome of the PCR or LAMP test in which RNA is converted to DNA. Barring a few Indian manufacturers, the majority of RNA isolation kits are imported, and its non-availability often becomes a severe bottleneck for RT-PCR testing in large numbers across the country.

"An efficient way of capturing and concentrating the RNA from patient samples is the first critical step in the confirmatory tests of the COVID-19 virus. The innovative process of conjugating the RNA with magnetic nanoparticles and increasing their concentration in one place by applying a magnetic field is a breakthrough that allowed the high sensitivity of newly developed RT-LAMP test from SCTIMST. Indeed, multidisciplinary and lateral thinking are the hallmarks of good science, with this example fitting the bill!" said Professor Ashutosh Sharma, Secretary, DST.

The technology of Chitra Magna has been transferred to the Agappe Diagnostics Ltd Ernakulam. The company has already taken the Chitra GeneLAMP-N technology, which uses RT-LAMP for identification of the N gene of SARS-COV-2. It is a potential confirmatory test with accuracy matching RT-PCR in its initial validation at NIV by ICMR. The test kits are now being validated in larger test samples for ICMR approval, followed by a commercial manufacturing license from DCGI. Dr. Anoop Thekkuveettil and his team, who developed Chitra GeneLAMP–N has developed the technology of Chitra Magna. All technology transfers of Sree Chitra are nonexclusive. Sree Chitra is an Institute of national importance under the department of Science and Technology, Govt of India.

Tags : #Sreechitratirunalinstitute #Covid-19 #Professorashutoshsharma #Rnaextractionkit

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026